Prioritizing multipurpose prevention technology development and investments using a target product profile.

•Priority multipurpose prevention technology products focus on HIV, STI, and unintended pregnancy.•High-impact MPT must be optimized regarding drug and formulation type.•Drugs with established safety and efficacy and acceptable dosage forms are crucial.•Coordinated investment and collaborative MPT development are critical to success.